COHLHEPP RYAN (President and COO) sold 8.8% of their position (17.50K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $400.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/10/2026ACC: 0001470831-26-000883
DirectorOfficer· President and COO
Since Mar 2026
-17.50K
Net shares
Net seller
$400.7K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
17.50K acquired · 35K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+17.50K
Price / share
$3.79
Trade value
$66.32K
% of position
9.6%
9/8/2026
181.64K→199.14K
Common Stock
Direct
Shares
−14.06K
Price / share
$22.77
Trade value
$320.05K
% of position
7.1%
9/8/2026
199.14K→185.08K
Common Stock
Direct
Shares
−3.44K
Price / share
$23.43
Trade value
$80.66K
% of position
1.9%
9/8/2026
185.08K→181.64K
Total
Net shares
+0.00
Net value
-$334.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/8/2026 | M · Option Exercise | +17.50K | $3.79 | $66.32K | 9.6% | 181.64K | 199.14K |
| Common Stock Direct | 9/8/2026 | S · Sale | −14.06K | $22.77 | $320.05K | 7.1% | 199.14K | 185.08K |
| Common Stock Direct | 9/8/2026 | S · Sale | −3.44K | $23.43 | $80.66K | 1.9% | 185.08K | 181.64K |
| Total | +0.00 | -$334.39K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.50K shares
Shares
−17.50K
Strike price
3.7898
Held after
34.25K
Exercisable
—
9/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.50K shares | 9/8/2026 | M · Option Exercise | −17.50K | 3.7898 | — | 34.25K |